News

Filter

Actelion bid for Ceptaris looks secured as FDA approves Valchlor

26-08-2013

Privately-held USA-based Ceptaris Therapeutics revealed yesterday (August 26) that the US Food and Drug…

ActelionBiotechnologyCeptaris TherapeuticsDermatologicalsMergers & AcquisitionsNorth AmericaRegulationValchlor

Actelion to reinforce portfolio with acquisition

01-08-2013

Through a US subsidiary, Switzerland-based Actelion (SIX: ATLN), Europe's largest biotech firm, has entered…

ActelionBiotechnologyCeptaris TherapeuticsMergers & AcquisitionsValchlor

COMPANY SPOTLIGHT

Menarini

Back to top